Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Oct 1, 2023
Q2 FY2023
As of Jul 2, 2023
Q1 FY2023
As of Apr 2, 2023
Q4 FY2022
As of Jan 1, 2023
Q3 FY2022
As of Oct 2, 2022
Q2 FY2022
As of Jul 3, 2022
Q1 FY2022
As of Apr 3, 2022
Q4 FY2021
As of Jan 2, 2022
Q3 FY2021
As of Oct 3, 2021
Q2 FY2021
As of Jul 4, 2021
Q1 FY2021
As of Apr 4, 2021
Q4 FY2020
As of Jan 3, 2021
Q3 FY2020
As of Sep 27, 2020
Q2 FY2020
As of Jun 28, 2020
Q1 FY2020
As of Mar 29, 2020
Q4 FY2019
As of Dec 29, 2019
Q3 FY2019
As of Sep 29, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 30, 2018
Assets
Current assets:
Cash and cash equivalents
Restricted cash and cash equivalents, current portion
Short-term investments
Accounts receivable, net
Contract assets
Loan receivables held for sale, net
Inventories
Advances to suppliers, current portion
Project assets - plants and land, current portion
Prepaid expenses and other current assets
Current assets of discontinued operations
Total current assets
Restricted cash and cash equivalents, net of current portion
Property, plant and equipment, net
Operating lease right-of-use assets
Advances to suppliers, net of current portion
Solar power systems leased, net
Goodwill
Other intangible assets, net
Other long-term assets
Long-term assets of discontinued operations
Total assets
Liabilities and Equity
Current liabilities:
Accounts payable
Accrued liabilities
Operating lease liabilities, current portion
Contract liabilities, current portion
Short-term debt, net
Convertible debt, current portion
Current liabilities of discontinued operations
Total current liabilities
Long-term debt
Long-term debt, net
Convertible debt, net of current portion
Operating lease liabilities, net of current portion
Contract liabilities, net of current portion
Other long-term liabilities
Long-term liabilities of discontinued operations
Total liabilities
Equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; none issued and outstanding as of October 1, 2023 and January 1, 2023
Common stock, $0.001 par value, 367,500 shares authorized; 189,834 shares issued and 175,302 shares outstanding as of October 1, 2023; 188,287 shares issued and 174,269 shares outstanding as of January 1, 2023
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Treasury stock, at cost: 14,532 shares of common stock as of October 1, 2023; 14,018 shares of common stock as of January 1, 2023
Total stockholders' equity
Noncontrolling interests in subsidiaries
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support